Chlamydia trachomatis
| Chlamydia trachomatis |
C. trachomatis inclusion bodies (brown) in a McCoy cell culture.
|
| Scientific classification |
|
|
| Binomial name |
Chlamydia trachomatis
Busacca, 1935 |
Chlamydia trachomatis is one of three bacterial species in the genus Chlamydia, family Chlamydiaceae, class Chlamydiae, phylum Chlamydiae, domain Bacteria. C. trachomatis is a gram-negative bacteria.
C. trachomatis was the first chlamydial agent discovered in humans. It was identified in 1907.[1]
It comprises two human biovars: trachoma and lymphogranuloma venereum (LGV).
Many, but not all,[2] C. trachomatis strains have an extrachromosomal plasmid.
Clinical significance
It has only been found living inside the cells of humans, causing the following conditions:
In men
In women
In both sexes
C. trachomatis has also been detected in some patients with temporomandibular joint disease (TMJ).
It may be treated with any of several antibiotics: azithromycin, erythromycin or doxycycline/tetracycline.
Identification
Chlamydia species are readily identified and distinguished from other chlamydial species using DNA-based tests.
Most strains of C. trachomatis are recognized by monoclonal antibodies (mAbs) to epitopes in the VS4 region of MOMP.[3] However, these mAbs may also crossreact with the other two Chlamydia species, Chlamydia suis and Chlamydia muridarum.
References
- ^ Budai I (2007). "Chlamydia trachomatis: milestones in clinical and microbiological diagnostics in the last hundred years: a review". Acta microbiologica et immunologica Hungarica 54 (1): 5–22. PMID 17523388.
- ^ Alexander S, Ison CA (2007). "Is New Variant Chlamydia trachomatis present in England and Wales?". doi:10.1136/sti.2007.026880. PMID 17855488.
- ^ Ortiz L, Angevine M, Kim SK, Watkins D, DeMars R (2000). "T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans". Infect. Immun. 68 (3): 1719–23. PMID 10678996.
|